Clinical trials

The goal of this clinical trial is to learn if using a WhatsApp-based chatbot called PROMBot-FA can help people recover after atrial fibrillation ablation. The main questions it aims to answer are: * Is the chatbot easy and practical for people to use after their procedure? * Do people find the chatbot helpful for sharing their symptoms and health updates? Researchers will compare follow-up care supported by the chatbot to standard hospital follow-up visits. Participants will: * Be randomly assigned to either use the chatbot or receive usual follow-up care. * Report their symptoms, well-being, and any problems after ablation for 3 months. * Complete short questionnaires about their experience using the chatbot. This study will help researchers understand whether chatbot follow-up is feasible and acceptable for people after atrial fibrillation ablation and guide future larger studies.